• Amphotericin B: Evidence, Principles and Limits

  2026-10-06

  This source-grounded overview explains how Amphotericin B is understood as a polyene antifungal antibiotic, what its membrane and immune effects may mean, and why potency claims cannot be transferred between assays or disease models. It also separates supplier-described properties from evidence provided by peer-reviewed research.

• BRD4–RAC1 Co-targeting in Breast Cancer

  2026-10-06

  The 2021 study by Ali et al. presents a preclinical co-targeting strategy that combines BRD4 and RAC1 inhibition across luminal-A, HER2-positive, and triple-negative breast cancer models. Its central mechanistic contribution is linking this combination to disruption of the c-MYC–G9a–FTH1 axis and reduced HDAC1-associated chromatin regulation, with effects on growth, stemness, migration, senescence, and xenograft tumor development.

• BCA Protein Quantification Kit K4102 Overview

  2026-10-05

  APExBIO’s Bicinchoninic Acid Assay (BCA) Protein Quantification Kit, SKU K4102, is described as a research-use biochemical assay for low-concentration total protein measurement. No matched paper evidence was provided, so its stated performance and applicability cannot be independently assessed here.

• FPS-ZM1: RAGE Signaling Beyond Amyloid

  2026-10-05

  FPS-ZM1 is a selective RAGE inhibitor that offers a useful lens for interpreting amyloid beta signaling alongside emerging RAGE/POMC metabolic research. This article separates established product evidence from hypothesis-generating findings and defines where cross-disease comparisons remain unproven.

• Potassium Phosphate in the LNP Drying Equation

  2026-10-04

  A translational framework for understanding how potassium phosphate monobasic and buffer context may influence the evaluation of dried mRNA-lipid nanoparticles, grounded in the 2026 review by Zhen and colleagues.

• PreScission Protease (PSP): Product Overview

  2026-10-03

  PreScission Protease (PSP) is a supplier-described recombinant HRV 3C protease–GST fusion intended for conceptual use in affinity-tag removal during recombinant protein purification. No matched paper evidence was provided.

• Trichoderma Snef3255 Against Peanut Root-Knot Disease

  2026-10-02

  This study combines biological screening, field validation, and chromosome-level genomics to characterize Trichoderma harzianum Snef3255 as a potential control agent against Meloidogyne hapla in peanut. Its strongest contribution is the integration of measurable nematode suppression and yield responses with genomic candidates, including ThCP1 and ThLysM1, that may help explain Trichoderma–peanut interactions.

• AR Heterogeneity and Prostate Cancer Therapy Response

  2026-10-01

  Li et al. show that distinct androgen receptor expression states define different castration and enzalutamide responses in castration-resistant prostate cancer. By combining patient samples, engineered cell models, xenografts, RNA sequencing, and combination treatment experiments, the study identifies BCL-2 as a target for addressing AR-low or AR-negative disease.

• Miltefosine Research Workflows and Applications

  2026-10-01

  Miltefosine is a versatile pathway tool for studying PI3K/Akt-dependent signaling, cancer cell proliferation, and neutrophil differentiation. This practical guide connects rapid phosphorylation assays with longer hematopoietic workflows, emphasizing dose selection, orthogonal readouts, and troubleshooting.

• Amyloid Beta-Peptide (1-40) (human): Research Guide

  2026-09-30

  Amyloid Beta-Peptide (1-40) (human) is a synthetic 40-residue Aβ40 reagent for amyloid fibril formation study, neurotoxicity mechanism investigation, and Alzheimer's disease research. Its experimental meaning depends on peptide preparation state, because monomeric Aβ can produce cellular effects that are not interchangeable with fibrillar or mixed aggregates.

• Cycloheximide and Mitochondrial Translation Logic

  2026-09-30

  Cycloheximide is more than a translation-arrest reagent: it is a strategic perturbation for testing whether newly synthesized proteins sustain mitochondrial homeostasis, oxidative-stress resistance, and apoptosis control. This article connects the compound’s mechanism to recent findings on the DCLRE1A–SYVN1 axis in age-related cataract research and outlines a rigorous translational workflow.

• Protein A/G Magnetic Co-IP/IP Kit Workflow

  2026-09-29

  Translate the RNF8–DAPK1 interaction workflow from ischemic-stroke research into a practical, magnetic-bead assay strategy. The Protein A/G Magnetic Co-IP/IP Kit combines Fc-selective capture, rapid separation, and flexible elution for protein-complex isolation, western blotting, and carefully planned mass-spectrometry workflows.

• TRPV1+ Nerves Suppress Inflammation via Reflexes

  2026-09-29

  Song et al. show that activating TRPV1+ peripheral sensory nerves at the nape can suppress systemic inflammation through coordinated somato-autonomic reflexes. The study connects peripheral stimulation with brainstem activation, corticosterone and catecholamine release, autonomic-splenic signaling, and inflammation-related transcriptional changes in the spleen.

• SUMO Protease (Ulp): Practical Cleavage Guide

  2026-09-28

  SUMO Protease (Ulp), an Ulp1 protease, removes SUMO fusion tags by cleaving immediately downstream of the SUMO C-terminal Gly-Gly motif. It is intended for SUMO-tagged recombinant proteins and controlled purification workflows, not for unrelated affinity tags or as a universal protein degradation reagent.

• Idoxuridine (B1773): Assay Design and Troubleshooting

  2026-09-28

  Learn how to use Idoxuridine (SKU B1773) as an experimental perturbation in antiviral and cell-based studies without confusing viral inhibition with host-cell toxicity. This scenario-driven guide covers solubility, controls, interpretation, storage, and practical supplier-selection criteria.

7992 records 1/533 page Next 12345 下5页 Last page